Compounds > clorazepate dipotassium
Page last updated: 2024-09-05

clorazepate dipotassium and alfuzosin

clorazepate dipotassium has been researched along with alfuzosin in 1 studies

Compound Research Comparison

Studies
(clorazepate dipotassium)		Trials
(clorazepate dipotassium)		Recent Studies (post-2010)
(clorazepate dipotassium)		Studies
(alfuzosin)		Trials
(alfuzosin)		Recent Studies (post-2010) (alfuzosin)
3259011427127120

Protein Interaction Comparison

ProteinTaxonomyclorazepate dipotassium (IC50)alfuzosin (IC50)
AcetylcholinesteraseHomo sapiens (human)0.018
Alpha-1D adrenergic receptorHomo sapiens (human)0.023
Alpha-1A adrenergic receptorHomo sapiens (human)0.023
Alpha-1B adrenergic receptorHomo sapiens (human)0.023

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
André, MC; Antunes, J; Filipe, P; Pacheco, D; Silva, R; Soares de Almeida, LM1

Other Studies

1 other study(ies) available for clorazepate dipotassium and alfuzosin

ArticleYear
Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis.
    Dermatology online journal, 2010, Jun-15, Volume: 16, Issue:6

    Topics: Adult; Amitriptyline; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzodiazepines; Carbamazepine; Clorazepate Dipotassium; Drug Eruptions; Eosinophilia; Glatiramer Acetate; Humans; Interferon beta-1a; Interferon-beta; Liver; Male; Multiple Sclerosis; Natalizumab; Peptides; Quinazolines; Thrombocytopenia

2010